Jessica Hagen

Molly Gibson, president of future science at Lila Sciences, explains how the company's superintelligence will reshape research across life, chemical and material sciences.

The partners will develop and clinically validate an AI tool that integrates into EHRs to accelerate the diagnosis of hypophosphatasia, a rare genetic bone disorder.

Kidd's company will use 1,000 Bitcoin and additional cash to acquire the interest, and the former Ripple chief risk officer will become CEO and chairman of the board.

The company is offering 7.9 million of its common stock at an initial price of $19 per share, with shares trading under the ticker symbol OMDA.

Alexandre Momeni, a partner at General Catalyst, describes how the VC firm funds visionary founders building frontier technologies while balancing high-risk bets with responsible innovation and strategic portfolio construction.

The company will grow its clinical team and expand its offerings across GI partner clinics representing 700 physicians, after an 800% rise in patient volume.

The company aims to create a tech-driven, interoperable healthcare system that improves the patient experience while streamlining communication across brands.

Calm Health, which works with employers and health providers and plans to offer virtual mental health support, will first roll out in the UK and Canada. 

The healthcare engagement company, which focuses on vulnerable populations, acquired the food delivery company, thanks to a $47.5 million investment.

Jayme Strauss, chief commercial and clinical officer at Precision Neuroscience, joined MobiHealthNews to discuss the company's brain-computer interface aimed at allowing individuals to control digital devices using their thoughts.